Company · CIK 0001135906
EPIRUS Biopharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AEPIRUS Biopharmaceuticals, Inc.0001654954-17-001048 · 73.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-16-135667 · 19.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-16-134031 · 24.6 KBSEC(opens sec.gov)
- SC 13G/AEPIRUS Biopharmaceuticals, Inc.0001137774-16-000252 · 9.3 KBSEC(opens sec.gov)
- SC 13G/AEPIRUS Biopharmaceuticals, Inc.0000315066-16-006007 · 8.7 KBSEC(opens sec.gov)
- SC 13G/AEPIRUS Biopharmaceuticals, Inc.0000053417-16-000384 · 9.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-16-130852 · 27.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-16-127110 · 22.0 KBSEC(opens sec.gov)
- 4Insider trades0001104659-16-124527 · 6.6 KBSEC(opens sec.gov)
- 4Insider trades0001104659-16-124526 · 6.6 KBSEC(opens sec.gov)
Insiders
- 5AM VENTURES III, L.P.10% Owner
- ALDRICH RICHARDDirector
- ANGIOTECH PHARMACEUTICALS INC10% Owner
- Aurentz VincentChief Business Officer
- BAIRD LYNN GSenior VP - Regulatory Affairs
- BIOTECHNOLOGY VALUE FUND L PDirect Beneficial Owner
- BONDERMAN DAVID10% Owner
- Borisy AlexisDirector, CEO & President
- BUCHI J KEVINDirector
- BVF INC/IL10% Owner
Tickers
No tickers on record.
Addresses
business
699 BOYLSTON ST 8TH FLOOR
BOSTON, MA, 02116
mailing
699 BOYLSTON ST 8TH FLOOR
BOSTON, MA, 02116
Former names
- Zalicus Inc.2014-07-02
- COMBINATORX, INC2010-08-10
- COMBINATORX INC2004-02-26
Same industry